Cargando…

Novel multifunctional antibody approved for the treatment of breast cancer

Detalles Bibliográficos
Autores principales:	Mavilio, Domenico, Galluzzi, Lorenzo, Lugli, Enrico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2013
Materias:	Editor's Corner
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3661175/ https://www.ncbi.nlm.nih.gov/pubmed/23802090 http://dx.doi.org/10.4161/onci.24567

Ejemplares similares

Cancer immunotherapy turns viral
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Rejuvenated T cells attack old tumors
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Immunogenic cell death in radiation therapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2013)

Metabolic Clues: Novel Directives for Broad Treatment Strategies
por: Maiese, Kenneth
Publicado: (2010)

Marketed therapeutic antibodies compendium
por: Reichert, Janice M.
Publicado: (2012)

The tip of antibody-testing iceberg
Publicado: (2020)

Antibody-drug conjugates: Present and future
por: Beck, Alain, et al.
Publicado: (2013)

Antibodies to watch in 2014: Mid-year update
por: Reichert, Janice M
Publicado: (2014)

Marking the onset of oxidative stress: Biomarkers and novel strategies
por: Maiese, Kenneth
Publicado: (2009)

Identifying targets for diagnosis, prognosis, and treatment
por: Dalmau, Josep
Publicado: (2015)

Learning from adverse treatment effects
por: Dalmau, Josep
Publicado: (2019)

Axicabtagene Ciloleucel: The First FDA-Approved CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
por: King, Amber C., et al.
Publicado: (2019)

Diagnostic and treatment challenges, a new section in N2
por: Dalmau, Josep
Publicado: (2018)

Belantamab Mafodotin-blmf: A Novel Antibody-Drug Conjugate for Treatment of Patients With Relapsed/Refractory Multiple Myeloma
por: Ketchum, Emily Behren, et al.
Publicado: (2022)

Telomeres in cancer therapy
por: Blasco, María A
Publicado: (2001)

Can the exome and the immunome converge on the design of efficient cancer vaccines?
por: Kroemer, Guido, et al.
Publicado: (2012)

Welcoming Paul Dent as Assistant Editor-in-Chief of Cancer Biology & Therapy
por: El-Deiry, Wafik S
Publicado: (2013)

Targeting PD-1/PD-L1 interactions for cancer immunotherapy
por: Zitvogel, Laurence, et al.
Publicado: (2012)

Informed consent and ethics committee approval in laboratory medicine
por: Borovecki, Ana, et al.
Publicado: (2018)

Sacituzumab Govitecan for Treatment of Refractory Triple-Negative Metastatic Breast Cancer
por: Fleming, Patrick J., et al.
Publicado: (2021)

Alpelisib: A Novel Therapy for Patients With PIK3CA-Mutated Metastatic Breast Cancer
por: Wilhoit, Tori, et al.
Publicado: (2020)

Market competition among manufacturers of novel high-risk therapeutic devices receiving FDA premarket approval between 2001 and 2018
por: Rathi, Vinay K, et al.
Publicado: (2023)

Ribociclib and Abemaciclib: CDK4/6 Inhibitors for the Treatment of Hormone Receptor–Positive Metastatic Breast Cancer
por: Byers, Kristina F.
Publicado: (2021)

Inhibiting the inhibitors: Checkpoints blockade in solid tumors
por: Mavilio, Domenico, et al.
Publicado: (2013)

Teclistamab-cqyv: The First Bispecific T-Cell Engager Antibody for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
por: Hua, Gwen, et al.
Publicado: (2023)

Letter from the Editor
por: Schroeder, Renée, et al.
Publicado: (2013)

Lifelong companions: RNA helicases and their roles in RNA metabolism
por: Klostermeier, Dagmar
Publicado: (2013)

Note of appreciation to reviewers
por: Reichert, Janice M.
Publicado: (2013)

In this issue of Small GTPases
por: Ellerton, Elaine L.
Publicado: (2013)

Letter from the Editor
por: Cheng, C. Yan
Publicado: (2013)

Letter from the Editor
por: Ellis, Ronald, et al.
Publicado: (2013)

In this issue of Mobile Genetic Elements
por: Ellerton, Elaine L.
Publicado: (2013)

Letter from the Editor
por: Ellis, Ronald, et al.
Publicado: (2013)

Human Vaccines & Immunotherapeutics awards Top Reviewer of the Year
por: Ellis, Ronald, et al.
Publicado: (2013)

Special focus CRISPR-Cas
por: Marchfelder, Anita
Publicado: (2013)

Biomaterials and Bioengineering Tomorrow’s Healthcare
por: Jayasinghe, Suwan N.
Publicado: (2013)

In this issue of Worm
por: Ellerton, Elaine L.
Publicado: (2013)

The hormone factory skin never sleeps or Methusalem drugs and other ancient friends, revisited!
por: Reichrath, Jörg
Publicado: (2013)

Special Focus: Bioinformatics
por: Nawrocki, Eric P., et al.
Publicado: (2013)

Pentatricopeptide repeat proteins: A set of modular RNA-specific binders massively used for organelle gene expression
por: Giegé, Philippe
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_v6hodlpqva182qlq5cun47iq2i